HIV/AIDS
New findings from Spain, Greece and Taiwan in the area of HIV/AIDS described
Published in Hepatitis Weekly, September 4th, 2006
Study 1: A recent study from Spain has chronicled the effect of highly active anti-retroviral therapy (HAART) and hepatitis C virus (HCV) co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1 (HIV-1)-infected individuals.
"This study aimed to determine the effect of HAART and HCV co-infection on peripheral levels of interleukin (IL)-2, IL-10, IL-12 (p70), IL-18 and soluble tumor necrosis factor receptor type II (sTNFRII)," wrote C. Tornero and colleagues, San Francisco de Borja Hospital.
"Serum...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-09-04)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Chronic hepatitis B infection independently predicts diabetic renal outcome - Hepatitis C Therapy
Agaricus blazei extract affects hepatitis C gene expression and viral load - Hepatitis C Virus
Hepatitis C RNA synthesis requires polypyrimidine-tract-binding protein - Hepatitis C Virus
Specific hepatitis C virus gene expression identified in HCV/HIV coinfection - Apoptosis
Stellate cell apoptosis is promoted by a soluble hepatocyte mediator - Blood Safety
Hepatitis B virus DNA detected in HBsAg and anti-HBc negative blood bank donor - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
